Navigate Fool.com
Will EBS beat
the market?

Emergent BioSolutions (NYSE: EBS)

Community Rating: 4 Stars: Favorite

22.40 -0.41 (-1.80%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $22.81
Previous Close $22.81
Daily Range $22.24 - $22.82
52-Week Range $16.95 - $28.48
Market Cap $838.0M
P/E Ratio 43.04
Dividend (Yield) $0.00 (0.0%)
Volume 83,601
Average Daily Volume 225,759
Current FY EPS $0.00

How do you think EBS
will perform against the market?

Top EBS Bull/Bear Pitches


EnigmaDude (< 20)
Submitted October 3, 2011

Emergent BioSolutions receives award to supply 44.75 mln doses of BioThrax to U.S. Government over 5 Years for a total value of up to $1.25 bln

0 Replies Reply Report this Post

gopyerk (< 20)
Submitted March 8, 2013

Projecting earnings declines for 3 of 4 quarters coming up. I think in the long term there are some things to like here, but for the short run, when considering the negative growth picture I just don … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

You Shouldn't Ignore Gilead's Idelalisib

Gilead Sciences is widely known for its HIV drug portfolio and for its high-profile hep-C drug sofosbuvir. But it also has a potential winner with idelalisib, a blood cancer drug with a promising future.

Healthcare Stocks Adding to Day-Long Surge; Emergent BioSolutions Slumps After Street.com Downgrade

Sector Update: Healthcare

Healthcare Stocks Nudging Back into the Green; Emergent BioSciences Declines After Q1 Miss, Weak Q2

Healthcare Stocks Nudging Back into the Green; Emergent BioSciences Declines After Q1 Miss, Weak Q2 Outlook

Sector Update: Healthcare

Emergent BioSolutions to Webcast Presentation at Credit Suisse 2013 Healthcare Conference

Emergent BioSolutions to Release Third Quarter 2013 Financial Results and Conduct a Conference Call

Investing in Counteracting Biological and Chemical Agents

Biological and chemical agents are a lethal scourge of war, but Emergent Biosciences is developing countermeasures to a wide range of such agents.

Sector Update: Healthcare Shares Higher; eHealth Signs Agreement to Enroll Individuals

Sector Update: Healthcare

See More EBS News...





Emergent BioSolutions (EBS) Description

Emergent BioSolutions makes the only FDA-approved anthrax vaccine. Website: http://www.emergentbiosolutions.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks